3-(1,3,2-Dioxaborinan-2-yl)pyridine → HCID 23582064, compound
Reaction equation
[NH2:1][C:2]1[C:14]2[C:13]3[CH:12]=[CH:11][C:10](Cl)=[CH:9][C:8]=3[NH:7][C:6]=2[C:5]([C:16]([NH2:18])=[O:17])=[CH:4][N:3]=1.B1([C:25]2[CH:30]=[CH:29][CH:28]=[N:27][CH:26]=2)OCCCO1>>[NH2:1][C:2]1[C:14]2[C:13]3[CH:12]=[CH:11][C:10]([C:25]4[CH:26]=[N:27][CH:28]=[CH:29][CH:30]=4)=[CH:9][C:8]=3[NH:7][C:6]=2[C:5]([C:16]([NH2:18])=[O:17])=[CH:4][N:3]=1Participants
3
Procedure
The title compound was prepared from 1-amino-7-chloro-5H-pyrido[4,3-b]indole-4-carboxamide (Example 27, step 5) and pyridine-3-boronic acid 1,3-propanediol cyclic ester using conditions described in example 2.
Sources & evidence
- ORD record
- ord-b9ed55f5ad1542bc9edea09a8f6c4a23
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08518964B2
Reaction notes
Loading…